EP4014976
- Application Number
- EP21202979A
- Filing Date
- Feb 26, 2018
- Status
- Granted And Under Opposition
- Aug 2, 2024
- Grant Date
- Sep 4, 2024
- External Links
- Slate, Register, Google Patents
Bibliography
The patent EP4014976B1 was granted to Idorsia Pharmaceuticals on Sep 4, 2024 following the initial filing on Feb 26, 2018 under the application number EP21202979A . The current legal status of the patent is Granted And Under Opposition.
AI Generated Summary New
Patent Family
Patent Oppositions
Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.
Dossier Documents
The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.
Date
Description
Get instant alerts for new documents